Stock Analysis

Elekta (STO:EKTA B) Is Reinvesting At Lower Rates Of Return

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? One common approach is to try and find a company with returns on capital employed (ROCE) that are increasing, in conjunction with a growing amount of capital employed. This shows us that it's a compounding machine, able to continually reinvest its earnings back into the business and generate higher returns. Having said that, from a first glance at Elekta (STO:EKTA B) we aren't jumping out of our chairs at how returns are trending, but let's have a deeper look.

Return On Capital Employed (ROCE): What Is It?

Just to clarify if you're unsure, ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. To calculate this metric for Elekta, this is the formula:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.094 = kr1.4b ÷ (kr27b - kr12b) (Based on the trailing twelve months to October 2022).

Thus, Elekta has an ROCE of 9.4%. On its own that's a low return, but compared to the average of 7.3% generated by the Medical Equipment industry, it's much better.

Our analysis indicates that EKTA B is potentially undervalued!

roce
OM:EKTA B Return on Capital Employed December 9th 2022

Above you can see how the current ROCE for Elekta compares to its prior returns on capital, but there's only so much you can tell from the past. If you're interested, you can view the analysts predictions in our free report on analyst forecasts for the company.

What The Trend Of ROCE Can Tell Us

On the surface, the trend of ROCE at Elekta doesn't inspire confidence. Over the last five years, returns on capital have decreased to 9.4% from 14% five years ago. On the other hand, the company has been employing more capital without a corresponding improvement in sales in the last year, which could suggest these investments are longer term plays. It's worth keeping an eye on the company's earnings from here on to see if these investments do end up contributing to the bottom line.

Another thing to note, Elekta has a high ratio of current liabilities to total assets of 45%. This effectively means that suppliers (or short-term creditors) are funding a large portion of the business, so just be aware that this can introduce some elements of risk. Ideally we'd like to see this reduce as that would mean fewer obligations bearing risks.

Our Take On Elekta's ROCE

Bringing it all together, while we're somewhat encouraged by Elekta's reinvestment in its own business, we're aware that returns are shrinking. Additionally, the stock's total return to shareholders over the last five years has been flat, which isn't too surprising. In any case, the stock doesn't have these traits of a multi-bagger discussed above, so if that's what you're looking for, we think you'd have more luck elsewhere.

On a final note, we found 2 warning signs for Elekta (1 is a bit unpleasant) you should be aware of.

While Elekta isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets.

The New Payments ETF Is Live on NASDAQ:

Money is moving to real-time rails, and a newly listed ETF now gives investors direct exposure. Fast settlement. Institutional custody. Simple access.

Explore how this launch could reshape portfolios

Sponsored Content

Valuation is complex, but we're here to simplify it.

Discover if Elekta might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About OM:EKTA B

Elekta

A medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

Reasonable growth potential with adequate balance sheet and pays a dividend.

Weekly Picks

AL
RKLB logo
AlexLovell on Rocket Lab ·

Early mover in a fast growing industry. Likely to experience share price volatility as they scale

Fair Value:US$16.25241.5% overvalued
25 users have followed this narrative
0 users have commented on this narrative
11 users have liked this narrative
AG
Agricola
EXN logo
Agricola on Excellon Resources ·

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Fair Value:CA$31.898.8% undervalued
26 users have followed this narrative
7 users have commented on this narrative
13 users have liked this narrative
FU
FundamentallySarcastic
CCP logo
FundamentallySarcastic on Credit Corp Group ·

Moderation and Stabilisation: HOLD: Fair Price based on a 4-year Cycle is $12.08

Fair Value:AU$12.647.1% overvalued
7 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative

Updated Narratives

DA
davidlsander
QS logo
davidlsander on QuantumScape ·

An amazing opportunity to potentially get a 100 bagger

Fair Value:US$2556.6% undervalued
128 users have followed this narrative
10 users have commented on this narrative
0 users have liked this narrative
YI
AMZN logo
yiannisz on Amazon.com ·

Amazon: Why the World’s Biggest Platform Still Runs on Invisible Economics

Fair Value:US$231.383.8% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
YI
RUN logo
yiannisz on Sunrun ·

Sunrun Stock: When the Energy Transition Collides With the Cost of Capital

Fair Value:US$19.098.1% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TH
TheWallstreetKing
MVIS logo
TheWallstreetKing on MicroVision ·

MicroVision will explode future revenue by 380.37% with a vision towards success

Fair Value:US$6098.5% undervalued
122 users have followed this narrative
11 users have commented on this narrative
22 users have liked this narrative
RO
RockeTeller
SCZ logo
RockeTeller on Santacruz Silver Mining ·

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fair Value:CA$8686.1% undervalued
81 users have followed this narrative
8 users have commented on this narrative
23 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$250.3929.0% undervalued
972 users have followed this narrative
6 users have commented on this narrative
26 users have liked this narrative